Annual Accounts Payable
$10.65 M
+$4.81 M+82.39%
December 31, 2023
Summary
- As of February 8, 2025, COGT annual accounts payable is $10.65 million, with the most recent change of +$4.81 million (+82.39%) on December 31, 2023.
- During the last 3 years, COGT annual accounts payable has risen by +$9.92 million (+1355.60%).
- COGT annual accounts payable is now at all-time high.
Performance
COGT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$15.06 M
+$6.09 M+67.81%
September 30, 2024
Summary
- As of February 8, 2025, COGT quarterly accounts payable is $15.06 million, with the most recent change of +$6.09 million (+67.81%) on September 30, 2024.
- Over the past year, COGT quarterly accounts payable has increased by +$6.09 million (+67.81%).
- COGT quarterly accounts payable is now -3.24% below its all-time high of $15.56 million, reached on March 31, 2024.
Performance
COGT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
COGT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.4% | +67.8% |
| 3 y3 years | +1355.6% | +246.3% |
| 5 y5 years | +601.5% | +2283.1% |
COGT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +205.9% | -3.2% | +332.4% |
| 5 y | 5-year | at high | +1355.6% | -3.2% | +4681.3% |
| alltime | all time | at high | +1355.6% | -3.2% | +4681.3% |
Cogent Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.06 M(+67.8%) |
| Jun 2024 | - | $8.97 M(-42.3%) |
| Mar 2024 | - | $15.56 M(+46.1%) |
| Dec 2023 | $10.65 M(+82.4%) | $10.65 M(+8.0%) |
| Sep 2023 | - | $9.87 M(+37.8%) |
| Jun 2023 | - | $7.16 M(+71.6%) |
| Mar 2023 | - | $4.17 M(-28.6%) |
| Dec 2022 | $5.84 M(+67.7%) | $5.84 M(+42.7%) |
| Sep 2022 | - | $4.09 M(+17.2%) |
| Jun 2022 | - | $3.49 M(-13.0%) |
| Mar 2022 | - | $4.01 M(+15.3%) |
| Dec 2021 | $3.48 M | $3.48 M(-19.9%) |
| Sep 2021 | - | $4.35 M(+118.3%) |
| Jun 2021 | - | $1.99 M(+532.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $315.00 K(-57.0%) |
| Dec 2020 | $732.00 K(-77.0%) | $732.00 K(+14.6%) |
| Sep 2020 | - | $639.00 K(+1.1%) |
| Jun 2020 | - | $632.00 K(+0.6%) |
| Mar 2020 | - | $628.00 K(-80.3%) |
| Dec 2019 | $3.18 M(+109.5%) | $3.18 M(+99.7%) |
| Sep 2019 | - | $1.59 M(-4.0%) |
| Jun 2019 | - | $1.66 M(+9.3%) |
| Dec 2018 | $1.52 M(+12.9%) | $1.52 M(+89.2%) |
| Sep 2018 | - | $803.00 K(-51.7%) |
| Jun 2018 | - | $1.66 M(-46.0%) |
| Mar 2018 | - | $3.08 M(+129.0%) |
| Dec 2017 | $1.35 M(-7.4%) | $1.35 M |
| Dec 2016 | $1.45 M | - |
FAQ
- What is Cogent Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Cogent Biosciences?
- What is Cogent Biosciences annual accounts payable year-on-year change?
- What is Cogent Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cogent Biosciences?
- What is Cogent Biosciences quarterly accounts payable year-on-year change?
What is Cogent Biosciences annual accounts payable?
The current annual accounts payable of COGT is $10.65 M
What is the all time high annual accounts payable for Cogent Biosciences?
Cogent Biosciences all-time high annual accounts payable is $10.65 M
What is Cogent Biosciences annual accounts payable year-on-year change?
Over the past year, COGT annual accounts payable has changed by +$4.81 M (+82.39%)
What is Cogent Biosciences quarterly accounts payable?
The current quarterly accounts payable of COGT is $15.06 M
What is the all time high quarterly accounts payable for Cogent Biosciences?
Cogent Biosciences all-time high quarterly accounts payable is $15.56 M
What is Cogent Biosciences quarterly accounts payable year-on-year change?
Over the past year, COGT quarterly accounts payable has changed by +$6.09 M (+67.81%)